Ocrelizumab and Other CD20+ B-Cell-Depleting Therapies in Multiple Sclerosis.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics

Gelfand JM, Cree BAC, Hauser SL. Ocrelizumab and Other CD20+ B-Cell-Depleting Therapies in Multiple Sclerosis. Neurotherapeutics. 2017 Jul 10.

2017
http://profiles.ucsf.edu/profile/168388445
28695471

Gelfand JM, Cree BAC, Hauser SL